Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Annales De Biologie Clinique|January 1, 1990
Comparative measurement of progesterone receptors in breast cancer by biochemical and immunoenzymatic assaysT Métayé, J Y Bounaud, F Begon
Clinical Chemistry|December 1, 1988
One-step chemiluminescent immunoassay of free thyroxin with acridinium-ester-labeled thyroxin evaluated and compared with a two-step radioimmunoassayJ Y Bounaud, M P Bounaud, F Begon
Schweizerische Medizinische Wochenschrift|October 4, 1975
[The treatment of myeloproliferative syndromes]P Maurice
European Journal of Cancer & Clinical Oncology|March 1, 1988
Breast cancer estrogen receptor assays: assessment of a direct hyperbolic fitting to analyse multipoint binding dataJ Y Bounaud, M P Bounaud, T Metayer, et al.
Medical Informatics = Medecine Et Informatique|January 1, 1979
A computer-aided system for the diagnosis of hepato-biliary diseases. A comparison with the performance of physiciansF Begon, A M Lockhart, J M Métreau, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 1, 1996
Inhibitions of protein kinases and protein phosphatases have opposite effects on thyrotropin-stimulated cAMP accumulation in human thyroid cellsT Métayé, D Sarrouilhe, J L Kraimps, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1989
[Evolution of salivary estradiol levels during the spontaneous menstrual cycle. Correlation between saliva and plasma]J Berthonneau, F Begon, J Y Bounaud, et al.
Monographs of the American Association on Mental Deficiency (1982)|January 1, 1982
Self-injurious behavior prevalence and relationships to environmental eventsP Maurice, G Trudel
The Journal of Urology|January 1, 1997
Serum-to-urinary prostate specific antigen ratio: its impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 ng./mlJ Irani, C Millet, P Levillain, et al.
European Urology|January 1, 1996
Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancerJ Irani, C Millet, P Levillain, et al.
Pageof 13